Skip to content
2000
Volume 21, Issue 20
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Drug-in-adhesive transdermal drug delivery matrix exploits intimate contact of the carrier with stratum corneum, the principal skin barrier to drug transport, to deliver the actives across the skin and into the systemic circulation. The main application challenges of drug-in-adhesive matrix lie in the physicochemical properties of skin varying with age, gender, ethnicity, health and environmental condition of patients. This in turn poses difficulty to design a universal formulation to meet the intended adhesiveness, drug release and drug permeation performances. This review focuses on pressure-sensitive adhesives, and their adhesiveness and drug release/permeation modulation mechanisms as a function of adhesive molecular structure and formulation attributes. It discusses approaches to modulate adhesive tackiness, strength, elasticity, hydrophilicity, molecular suspension capability and swelling capacity, which contribute to the net effect of adhesive on skin bonding, drug release and drug permeation.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612821666150428130215
2015-06-01
2025-05-02
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612821666150428130215
Loading

  • Article Type:
    Research Article
Keyword(s): Drug-in-adhesive; pressure-sensitive adhesive; transdermal drug delivery
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test